Infertility Clinical Trial
Official title:
Embryonic Developmental Rates and Pregnancies Following the Vitrification of Human Oocytes Using Two Methodologies.
The investigators are going to compare embryo developmental rates of human eggs following
freezing in two different freezing methods. The investigators are going to compare the
pregnancy rates following transfer to patients as well.
Null Hypothesis: The type of vitrification methodology used will not have an impact on the
following:
- Survival rates
- Embryonic developmental rates
- Pregnancy and implantation rates.
Randomization of Oocytes: Oocytes will be denuded approximately 1-2 hours post retrieval and
graded for maturity. Only the Metaphase II oocyte will be vitrified. Half of the oocytes
within each donor will be randomized to the following treatments.
1. Frozen using an open system using a metal grid to hold the oocyte. Three to five
oocytes will be frozen on the metal grid using a minute amount (< 2-3 µls) of
cryoprotectant. A top is put over the metal grid to protect the oocytes. This system
has proven to be successful in limited cases in Peru. This is an open system of
vitrification where the oocytes are directly plunged into liquid nitrogen. This will
serve as the control.
2. Frozen in closed straws using a methodology developed by Jim Stachecki. Three to five
oocytes will be frozen in ¼ cc straws. This is very similar to the method used to
successfully vitrify blastocysts. This will be the experimental treatment.
Null Hypothesis: The type of vitrification methodology used will not have an impact on the
following:
- Survival rates
- Embryonic developmental rates
- Pregnancy and implantation rates. Measured Outcomes The effect of vitrification
technique will be measured using the appropriate statistical analysis on the following
parameters.
1. Survival rates following thawing.
2. Effect of vitrification technique on how oocytes react to ICSI. The parameters
have been previously defined at NCRS.
3. Normal fertilization rates, abnormal fertilization rates and rates of degeneration
following ICSI.
4. Embryonic development rates. Embryos will be cultured until Day 5/6 and rate as
well as quality of blastocyst will be noted.
5. Pregnancy and implantation rates following replacement in endometrial prepared
recipients.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A |